UW researchers are modifying the treatment of unresectable pancreatic cancer to involve low-dose chemotherapy and are actively
conducting therapeutic trials of different treatment adjuvants. So far, results are encouraging, and patients with pancreatic cancer
can have excellent quality of life and prolonged remissions.
In addition, there is a growing body of evidence that multiple factors, including diet, exercise, and stress management, can also
affect one’s risk for developing cancer of the pancreas or other digestive organs. Additional research studies in alternative adjuvants
to traditional therapies may shed further light on the role of these nutritional and behavioral factors in both prevention and treatment.